References
- Albertini, R. J., Anderson, D., Douglas, G. R., Hagmar, L., Hemminki, K., Merlo, F., et al. (2000). IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans: International Programme on Chemical Safety. Mutat Res 463:111–172.
- Bignold, L. P. (2009). Mechanisms of clastogen-induced chromosomal aberrations: a critical review and description of a model based on failures of tethering of DNA strand ends to strand-breaking enzymes. Mutat Res 681:271–298.
- Choudhury, R. C., Misra, S., Jagdale, M. B., Palo, A. K. (2002). Induction and transmission of cytogenetic toxic effects of 5-fluorouracil in male germline cells of Swiss mice. J Exp Clin Cancer Res 21:277–282.
- Duesberg, P., Rasnick, D. (2000). Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskel 47:81–107.
- Eastmond, D. A., Tucker, J. D. (1989). Identification of aneuplody-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen 13:34–43.
- Fenech, M. (2000). The in vitro micronucleus technique. Mutat Res 455:81–95.
- Fenech, M. (2007). Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104.
- Fenech, M., Chang, W. P., Kirsch-Volders, M., Holland, N., Bonassi, S., Zeiger, E. (2003). HUMN project: detailed description of the scoring criteria for the cytokinesis–block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65–75.
- Galic, B. (2007). Removal of skin changes. WO 2007/107809. European Patent Application EP 1996514. U.S. Patent Application 20090238897.
- Hagmar, L., Stromberg, U., Bonassi, S., Hansteen, I. L., Knudsen, L. E., Lindholm, C., et al. (2004). Impact of types of lymphocyte chromosomal aberrations on human cancer risk. Cancer Res 64:2258–2263.
- Hall, D. C. (2005). Boronic acids. New York: John Wiley and Sons.
- Hamid, R., Rotshteyn, Y., Rabadi, L., Parikh, R., Bullock, P. (2004). Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18:703–710.
- Mitelman, F. (1995). ISCN, an international system for human cytogenetic nomenclature. cytogenetics and cell genetics. Basel, Switzerland: S. Karger AG.
- Nersesyan, A., Perrone, E., Roggieri, P., Bolognesi, C. (2006). Cytogenetic toxicity of cycloplatam in human lymphocytes: detection by the micronucleus test and fluorescence in situ hybridization. Anticancer Drugs 17:289–295.
- Othman El-Mahdy Sayed, O. (2000). Cytogenetic effect of the anticancer drug, epirubicin, on Chinese hamster cell line in vitro. Mutat Res 468:109–115.
- Rossner, P., Boffetta, P., Ceppi, M., Bonassi, S., Smerhovsky, Z., Landa, K., et al. (2005). Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113:517–520.
- Ryss, I. G., Slutskaya, M. M. (1951). Report on the platinum sector. Akad Nauk SSSR 26:216.
- Tucker, J. D., Preston, R. J. (1996). Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutat Res 365:147–159.
- Uno, Y. (2006) Understanding of genotoxic mechanism of action for carcinogen risk assessment to humans; a commentary to the discussion at the 4th International Workshop on Genotoxicity Testing (IWGT). Genes Environ 28:38–39.